Stocks and Investing
by (remove) : Liisa Bayko
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Liisa Bayko
RSSJSONXMLCSV
Tue, June 25, 2024
Tue, June 18, 2024
Thu, May 16, 2024
Wed, May 15, 2024
Thu, April 11, 2024
Mon, February 12, 2024
Tue, February 6, 2024
Fri, September 22, 2023
Tue, September 19, 2023
Wed, September 13, 2023
Wed, September 6, 2023
Tue, August 1, 2023
Thu, July 6, 2023
Mon, June 26, 2023
Tue, May 2, 2023
Thu, April 20, 2023
Tue, March 28, 2023
Wed, January 18, 2023
Wed, November 2, 2022
Wed, September 14, 2022
Fri, August 5, 2022
Tue, May 24, 2022
Mon, May 9, 2022
Tue, May 3, 2022
Tue, April 19, 2022
Fri, April 1, 2022
Thu, March 24, 2022
Wed, December 22, 2021
Tue, November 23, 2021
Mon, July 26, 2021

Liisa Bayko Maintained (ALNY) at Buy with Increased Target to $260 on, Jun 25th, 2024


Published on 2024-10-28 12:05:54 - WOPRAI, Liisa Bayko
  Print publication without navigation


Liisa Bayko of Evercore ISI Group, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $210 to $260 on, Jun 25th, 2024.

Liisa has made no other calls on ALNY in the last 4 months.



There are 5 other peers that have a rating on ALNY. Out of the 5 peers that are also analyzing ALNY, 0 agree with Liisa's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Liisa


  • Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $275 on, Monday, June 24th, 2024
  • Kostas Biliouris of "BMO Capital" Maintained at Buy and Held Target at $234 on, Monday, June 24th, 2024
  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $400 on, Monday, June 24th, 2024
  • Whitney Ijem of "Canaccord Genuity" Maintained at Strong Buy and Held Target at $283 on, Friday, June 21st, 2024
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy and Held Target at $225 on, Friday, May 3rd, 2024
Contributing Sources